University of Zurich leverages AI to identify antibiotic-resistant bacteria
Researchers from the University of Zurich (UZH) in Switzerland have identified antibiotic-resistant bacteria by leveraging AI, marking a first step…
All articles by Archana Rani
Archana Rani
-
-
Penumbra completes enrolment for THUNDER study to treat ischemic stroke
US-based Penumbra has completed enrolment for the THUNDER Investigational Device Exemption study of its advanced thrombectomy technology for acute ischemic…
-
Exo launches SweepAI for smarter ultrasound scanning
Medical imaging software and devices company Exo has launched SweepAI, an AI-driven cardiac and lung scanning ultrasound application. Approved by…
-
Toro Neurovascular’s catheter trial begins with first patient in Japan
Toro Neurovascular has announced the successful treatment of the first patient in a first-in-man clinical trial of its Toro 88…
-
Proteomics reports positive results for PromarkerEso oesophageal cancer test
Proteomics International has reported positive results from the clinical validation study of its PromarkerEso diagnostic blood test, designed to detect…
-
GT Medical secures venture loan to expand reach of brain tumour treatment
GT Medical Technologies has secured a $35m venture loan facility from Horizon Technology Finance, an affiliate of Monroe Capital, for…
-
Inflammatix secures $57m to advance TriVerity test
Inflammatix has secured $57m in a Series E financing round to advance its TriVerity acute infection and sepsis test. Led…
-
Biocomposites to start NanoBone bone graft products distribution in UK
Medical device company Biocomposites is set to commence UK distribution of its NanoBone product range. The range includes NanoBone SBX…
-
FDA authorises hearing aid software for AirPods Pro
The US Food and Drug Administration (FDA) has granted authorisation for the first over-the-counter (OTC) hearing aid software, designed for…
-
Syantra raises $4.9m for early breast cancer detection technology
Precision biotechnology company Syantra has secured C$4.9m ($3.60m) in Series A-1 funding to advance the clinical validation and commercialisation of…